136 related articles for article (PubMed ID: 1933810)
21. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
[TBL] [Abstract][Full Text] [Related]
22. Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival.
Yuan J; Hennessy C; Corbett IP; Dykin R; Givan AL; Shenton BK; Henry JA; Wright C; Lennard TW
Br J Surg; 1991 Jul; 78(7):844-8. PubMed ID: 1678669
[TBL] [Abstract][Full Text] [Related]
23. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
24. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
[TBL] [Abstract][Full Text] [Related]
25. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Jonsson H
Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of the DNA content of human breast cancer.
Dowle CS; Owainati A; Robins A; Burns K; Ellis IO; Elston CW; Blamey RW
Br J Surg; 1987 Feb; 74(2):133-6. PubMed ID: 3815031
[TBL] [Abstract][Full Text] [Related]
27. DNA ploidy and TLI in association with other prognostic parameters in breast cancer.
Midulla C; Cenci M; De Iorio P; Pisani T; Bonaccorsi A; De Marchis L; Nofroni I; Vecchione A
Anticancer Res; 1999; 19(1A):381-4. PubMed ID: 10226571
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Acta Oncol; 1992; 31(2):157-65. PubMed ID: 1622630
[TBL] [Abstract][Full Text] [Related]
29. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
31. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
32. Nuclear DNA content and pathology in radically treated pancreatic carcinoma. The prognostic significance of DNA ploidy, histology and nuclear grade.
Rugge M; Sonego F; Sessa F; Leandro G; Capella C; Sperti C; Pasquali C; Di Mario F; Pedrazzoli S; Ninfo V
Cancer; 1996 Feb; 77(3):459-66. PubMed ID: 8630952
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Project Collaborative Group.
Bergers E; van Diest PJ; Baak JP
Cancer; 1996 Jun; 77(11):2258-66. PubMed ID: 8635093
[TBL] [Abstract][Full Text] [Related]
34. DNA ploidy in endometrial carcinoma: major objective prognostic factor.
Britton LC; Wilson TO; Gaffey TA; Cha SS; Wieand HS; Podratz KC
Mayo Clin Proc; 1990 May; 65(5):643-50. PubMed ID: 2348728
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
36. Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer.
Toikkanen S; Joensuu H; Klemi P
Am J Clin Pathol; 1990 Apr; 93(4):471-9. PubMed ID: 2321579
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
[TBL] [Abstract][Full Text] [Related]
38. DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma.
Takes RP; Baatenburg de Jong RJ; van Blommestein R; Hermans J; van Krieken HH; Cornelisse CJ
Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):1015-20. PubMed ID: 12450177
[TBL] [Abstract][Full Text] [Related]
39. Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy.
Yuan J; Hennessy C; Givan AL; Corbett IP; Henry JA; Sherbet GV; Lennard TW
Br J Cancer; 1992 Mar; 65(3):461-5. PubMed ID: 1348424
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
